Filing Details
MAIA Biotechnology, Inc. (AMEX:MAIA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedAMEX:MAIA
MAIA Biotechnology, Inc. (MAIA) Files Quarterly Report for Q0
MAIA Biotechnology, Inc. (AMEX:MAIA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
MAIA Biotechnology, Inc. (AMEX:MAIA) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- MAIA Biotechnology, Inc. filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.41 with a market capitalization of $60.5 million as of the filing date.
- The quarterly report contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing, though with less detail than the annual 10-K report.
Market Context
MAIA Biotechnology, Inc.'s stock currently trades at $1.41 with a market capitalization of $60.5M.
The 10-Q provides MAIA Biotechnology, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for MAIA Biotechnology, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MAIA Stock Page
Frequently Asked Questions
Where can I read MAIA's SEC filings?
Browse all filings on our MAIA SEC filings page.
What types of SEC filings does MAIA Biotechnology, Inc. file?
Public companies like MAIA Biotechnology, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.